510(k) Report

510(k) · Cleared

Recalled · 2010

Autotransfusion Appartus (Autolog)

K972894510(k) TraditionalCleared Apr 27, 1998265-day reviewClass II21 CFR 868.5830Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Blood Management · CAC Apparatus, Autotransfusion

Cleared on Apr 27, 1998 after a 265-day review. The FDA summary names its predicate without a number. 4 later devices descend from it. It has been recalled once.

Decided
Apr 27, 1998
Review
265 days
Class
Class II
Product code
CAC
Recalls
1
Predicates
0

4 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared1998: 1 descendant cleared2010: 1 descendant cleared2018: 1 descendant cleared1995200020052010201520202025
  1. This deviceK972894 Autotransfusion Appartus (Autolog)Medtronic Blood Management · 1998
  2. Descendant · cites it directly · 2 of its ownK982755 Modification of Autotransfusion Apparatus (Autolog)Medtronic Blood Management · 1998
  3. Descendant · 2 generations on · 1 of its ownK093535 Autolog Autotransfusion SystemMedtronic, Inc. · 2010
  4. Descendant · 3 generations on · 0 of its ownK181954 autoLog IQ Autotransfusion SystemMedtronic Perfusion Systems · 2018
  5. Descendant · cites it directly · 0 of its ownK060482 Cytori Celution Cell Concentration DeviceCytori Therapeutics, Inc. · 2006

Most influential descendants

Showing 4 of 4 · See all
  • K982755Modification of Autotransfusion Apparatus (Autolog)Medtronic Blood Management · 1998 · cites it directly2descendants
  • K093535Autolog Autotransfusion SystemMedtronic, Inc. · 2010 · 2 generations on1descendant
  • K181954autoLog IQ Autotransfusion SystemMedtronic Perfusion Systems · 2018 · 3 generations on0descendants
  • K060482Cytori Celution Cell Concentration DeviceCytori Therapeutics, Inc. · 2006 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K972894Autotransfusion Appartus (Autolog)Medtronic Blood Management1998—
+1K982755Modification of Autotransfusion Apparatus (Autolog)Medtronic Blood Management1998—
+2K093535Autolog Autotransfusion SystemMedtronic, Inc.2010—
+3K181954autoLog IQ Autotransfusion SystemMedtronic Perfusion Systems2018—
+1K060482Cytori Celution Cell Concentration DeviceCytori Therapeutics, Inc.2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
200610
201010
201810
FIG. 1 — Lineage of K972894, 1998–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAC device

  1. #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Sequestra
Named without a submission number
—
*—ELMD 500 autotransfusion apparatus
Named without a submission number
—

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K982755Modification of Autotransfusion Apparatus (Autolog)Medtronic Blood Management19982
K060482Cytori Celution Cell Concentration DeviceCytori Therapeutics, Inc.20060

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 21, 2010Not classifiedZ-1939-2010Nonconforming Material/ComponentThe potential risks during the use of this power cord include electrical shock, delay in setup and therapy, interruption of therapy, device failure, and fires. Although Medtronic has received no reports of adverse events related to the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K982755 (Medtronic Blood Management, 1998) has gone furthest, with 2 descendants of its own.

How does its category compare?

All CAC devices

CAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAC

3in 2024

2008: 12010: 42011: 22012: 32013: 12014: 32016: 22017: 12018: 22019: 12020: 12021: 42022: 12023: 22024: 3
2007high 4 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAC

91in 2024

2010: 123 days median2012: 90 days median2014: 269 days median2021: 155 days median2024: 91 days median
2007high 269 (2014) · low 90 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAC

7in 2023

2007: 12008: 52009: 252010: 32011: 32013: 92017: 22018: 22019: 232023: 7, 2 Class I
2007high 25 (2009) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CAC

128in 2025

2007: 352008: 122009: 682010: 1152011: 9392012: 2492013: 1532014: 902015: 872016: 732017: 882018: 872019: 642020: 1082021: 732022: 652023: 392024: 1292025: 128
2007high 939 (2011) · low 12 (2008)2025

MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—135
20081—512
20090—2568
201041233115
20112—3939
20123900249
20131—9153
20143269090
20150—087
20162—073
20171—288
20182—287
20191—2364
20201—0108
20214155073
20221—065
20232—7 (2)39
20243910129
20250—0128
20260—0—

What is it indicated for?

The autoLog™ is intended for use in the collection, concentration, washing, and reinfusion of autologous blood. Such areas of application may include, but are not limited to, the following:

General, Cardiovascular, Orthopedic, Vascular, Plastic/Reconstructive, Obstetric/Gynecologic and Neurosurgical

Postoperative treatment areas

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K972894: Autotransfusion Appartus (Autolog).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K972894

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026